A Prospective Randomized Comparison of Ultrasound-guided Supraclavicular and Interscalene Block in Patients Undergoing Arthroscopic Shoulder Surgery
Overview
- Phase
- Not Applicable
- Intervention
- Supraclavicular Block
- Conditions
- Pain
- Sponsor
- Tokat Gaziosmanpasa University
- Enrollment
- 62
- Locations
- 1
- Primary Endpoint
- Postoperative Pain
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to compare the supraclavicular block to interscalene block in patients undergoing arthroscopic shoulder surgery.
Detailed Description
The aim of this study is to evaluate the efficacy of the supraclavicular block in comparison with interscalene block on postoperative pain, quality of recovery and side effects in patients undergoing arthroscopic shoulder surgery under general anesthesia.
Investigators
Tuğba Karaman
Assistant Professor, M.D.
Tokat Gaziosmanpasa University
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing shoulder surgery in American Society of Anesthesiologists physical status I-II
Exclusion Criteria
- •with a known allergy to study medications,
- •chronic opioid use,
- •ipsilateral upper limb neurological deficits,
- •severe respiratory disease,
- •coagulopathy
Arms & Interventions
Supraclavicular Block
Ultrasound guided supraclavicular block with 20 ml of 0.25% bupivacaine will be performed
Intervention: Supraclavicular Block
Supraclavicular Block
Ultrasound guided supraclavicular block with 20 ml of 0.25% bupivacaine will be performed
Intervention: Bupivacaine
Supraclavicular Block
Ultrasound guided supraclavicular block with 20 ml of 0.25% bupivacaine will be performed
Intervention: Ultrasound
Interscalene block
Ultrasound guided inter scalene block with 20ml of 0.25% bupivacaine will be performed.
Intervention: Interscalene Block
Interscalene block
Ultrasound guided inter scalene block with 20ml of 0.25% bupivacaine will be performed.
Intervention: Bupivacaine
Interscalene block
Ultrasound guided inter scalene block with 20ml of 0.25% bupivacaine will be performed.
Intervention: Ultrasound
Outcomes
Primary Outcomes
Postoperative Pain
Time Frame: up to postoperative 24 hours
The visual analog scale will be used for assessment
Secondary Outcomes
- Quality of recovery(in the postoperative 24 hours)
- Motor block(up to postoperative 24 hours)
- Sensory block(up to postoperative 24 hours)
- Adverse events(up to postoperative 24 hours)
- Analgesics requirement time(up to postoperative 24 hours)
- Systolic Blood pressure changes(at time of surgery)
- Heart rate changes(at time of surgery)